Safety, tolerability and pharmacokinetics of multiple once-daily dosing of oral semaglutide in healthy males and in males with type 2 diabetes

被引：0
|
作者：
Granhall, C. [1 ]
Donsmark, M. [1 ]
Golor, G. [2 ]
Sondergaard, F. L. [1 ]
Thomsen, M. [1 ]
机构：
[1] Novo Nordisk, Soborg, Denmark
[2] Parexel Int, Berlin, Germany
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
790
引用
收藏
页码：S362 / S363
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study
    Zhao, Xia
    Sheng, Xiao Yan
    Payne, Christopher D.
    Zhang, Xin
    Wang, Feng
    Cui, Yi Min
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (08): : 952 - 960
  • [22] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDY
    Zhao, Xia
    Payne, Christopher
    Wang, Feng
    Cui, Yiming
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378
  • [23] Comparison of Efficacy and Safety of Once-Daily Dosing and On-Demand Use of Udenafil for Type 2 Diabetes Patients with Erectile Dysfunction
    Yu, Hea Min
    Ryu, Ah Jeong
    Park, Soon Hyun
    Park, Sung Woo
    Cha, Bong Yun
    Park, Ie Byung
    Min, Kyung Wan
    Sung, Yeon Ah
    Kim, Tae Hwa
    Lee, Jae Min
    Park, Kang Seo
    DIABETES, 2014, 63 : A294 - A294
  • [24] Comparison of efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetes patients with erectile dysfunction
    Park, K. -S.
    Park, S.
    Lee, J.
    Cha, B.
    Park, S.
    Min, K.
    Sung, Y.
    Kim, T.
    Park, I.
    Moon, H.
    DIABETOLOGIA, 2012, 55 : S478 - S479
  • [25] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [26] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [27] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
  • [28] Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
    Hoimark, Lene
    Laursen, Torben
    Rungby, Jorgen
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 295 - 302
  • [29] Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
    Juliana Levy
    Roberta A Cobas
    Marília B Gomes
    Diabetology & Metabolic Syndrome, 2
  • [30] Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
    Levy, Juliana
    Cobas, Roberta A.
    Gomes, Marilia B.
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
12345